IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAH1. A total of 23 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $38,348,717 | -4.0% | 39,174,000 | 0.0% | 0.43% | -9.3% |
| Q2 2023 | $39,966,498 | +8.0% | 39,174,000 | +6.5% | 0.47% | +8.2% |
| Q1 2023 | $37,005,818 | +56.6% | 36,774,000 | +71.1% | 0.44% | +78.8% |
| Q4 2022 | $23,632,820 | +7.8% | 21,495,000 | 0.0% | 0.24% | +3.8% |
| Q3 2022 | $21,916,000 | +77.3% | 21,495,000 | +87.0% | 0.24% | +90.3% |
| Q2 2022 | $12,364,000 | +13.7% | 11,495,000 | +24.7% | 0.12% | +17.0% |
| Q1 2022 | $10,874,000 | +4.1% | 9,221,000 | +0.4% | 0.11% | +9.3% |
| Q4 2021 | $10,442,000 | +764.4% | 9,181,000 | +818.1% | 0.10% | +870.0% |
| Q3 2021 | $1,208,000 | +0.8% | 1,000,000 | 0.0% | 0.01% | +11.1% |
| Q2 2021 | $1,198,000 | +5.8% | 1,000,000 | 0.0% | 0.01% | -10.0% |
| Q1 2021 | $1,132,000 | 0.0% | 1,000,000 | 0.0% | 0.01% | +25.0% |
| Q4 2020 | $1,132,000 | +15.7% | 1,000,000 | 0.0% | 0.01% | -11.1% |
| Q3 2020 | $978,000 | – | 1,000,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 69,285,732 | $54,302,494 | 2.70% |
| CAMDEN ASSET MANAGEMENT L P /CA | 50,071,000 | $48,664,005 | 1.81% |
| Boussard & Gavaudan Investment Management LLP | 6,577 | $6,483,091 | 0.76% |
| READYSTATE ASSET MANAGEMENT LP | 12,000,000 | $11,722,800 | 0.59% |
| BRAIDWELL LP | 15,500,000 | $15,141,950 | 0.48% |
| WOLVERINE ASSET MANAGEMENT LLC | 39,174,000 | $38,348,717 | 0.43% |
| CSS LLC/IL | 5,500,000 | $5,379,280 | 0.35% |
| SHENKMAN CAPITAL MANAGEMENT INC | 3,239,000 | $3,239,825 | 0.24% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 15,174,000 | $14,823,481 | 0.07% |
| Calamos Advisors LLC | 9,500,000 | $9,281,500 | 0.05% |